Category: Cancer Treatments
Personalized Melanoma Vaccines: What the Phase 3 Intismeran Results Actually Show and What Remains Unknown
A personalized mRNA cancer vaccine has succeeded in a Phase 3 melanoma trial, but that does not mean researchers have developed a vaccine that prevents melanoma—or that all of …
Antibiotics Can Slow Growth of Skin Lymphoma Cells, Study Shows
Antibiotics Inhibit Skin Lymphoma A new study published in the journal Blood shows that antibiotics can be helpful in the treatment of people with a rare type of skin …
Targeting B7-H4 Protein with Antibody-Drug Conjugates Offers New Hope for Drug-Resistant Ovarian Cancer
A preclinical study by a team of oncologists and pharmacologists at Penn Medicine identifies a new target for recurrent ovarian cancer, a difficult-to-treat cancer. The work which was presented …
Immunotherapy Transforms Melanoma Outcomes: French Study Highlights Progress, Challenges, and Key Survival Data
Key Takeaways: Dual immunotherapy (anti-PD-1 + anti-CTLA-4) achieves 77% survival at 6.5 years in metastatic melanoma, compared to 69% with anti-PD-1 alone. Combination therapy boosts efficacy but increases severe …Prostate Cancer MRI Scans May Underestimate Tumor Size: UCLA Study Warns of Treatment Risks
Key Takeaways: Prostate cancer is the second leading cause of cancer death in U.S. men, but early detection boosts survival rates to nearly 100%. Age, family history, and race …Short-Term Rapamycin Treatment May Be Sufficient for Lifespan Extension, Reducing the Need for Lifelong Use
A team of researchers from the Max Planck Institute for Biology of Ageing has revealed that brief exposure to the macrolide drug rapamycin could have similar effects on lifespan …
The Science Behind Drugs to Treat CLL: How Biological Understanding Transformed Therapy
Key Takeaways Chronic lymphocytic leukemia (CLL) is a slow-growing blood cancer of B lymphocytes driven by impaired programmed cell death (apoptosis), abnormal survival signaling, and interactions with the surrounding …The IMPORT HIGH Trial: A Paradigm Shift in Early Breast Cancer Treatment with Simultaneous Integrated Boost
Breast cancer accounts for 12.5% of all new cancer cases each year worldwide, making it the most prevalent cancer at the moment. In 2020, an estimated 7.8 million women …